Get the Stockscreener App
51.32
1.66%
0.84
After Hours:
51.32
Omnicell Inc stock is traded at $51.32, with a volume of 359.26K.
It is up +1.66% in the last 24 hours and up +12.30% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$50.48
Open:
$50.51
24h Volume:
359.26K
Relative Volume:
0.71
Market Cap:
$2.30B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
102.64
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
+0.67%
1M Performance:
+12.30%
6M Performance:
+81.60%
1Y Performance:
+20.41%
1-Day Range:
$50.40
$51.40
1-Week Range:
$48.82
$51.40
52-Week Range:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
51.32 | 2.27B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Operating Room Management Market Innovations and Key Players: - openPR.com
Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention - TradingView — Track All Markets
Aug Patterns: What is Omnicell Incs TAM Total Addressable Market2025 Risk Factors & Weekly Top Performers Watchlists - baoquankhu1.vn
3 Reasons to Sell OMCL and 1 Stock to Buy Instead - Yahoo Finance
EV Market: Whats the analyst consensus on Bowman Consulting Group LtdDollar Strength & Advanced Technical Analysis Signals - baoquankhu1.vn
Omnicell stock price target raised to $53 from $46 at BofA Securities - Investing.com Canada
Sumitomo Mitsui Trust Group Inc. Sells 25,054 Shares of Omnicell, Inc. $OMCL - MarketBeat
Assessing Omnicell (OMCL) Valuation After Recent Share Price Momentum And High P/E Concerns - Yahoo Finance
Is Omnicell’s (OMCL) Analyst Upgrade Reframing the Risk‑Reward of Its Automation Strategy? - Sahm
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy - sharewise.com
All you need to know about Omnicell (OMCL) rating upgrade to buy - MSN
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - 01net
Omnicell (NASDAQ:OMCL) Sets New 12-Month HighWhat's Next? - MarketBeat
United States Automated Dispensing Machines Market to hit US$ - openPR.com
Omnicell upgraded at KeyBanc on Titan XT and competitive conversions - MSN
Omnicell (NASDAQ:OMCL) EVP Corey Manley Sells 6,106 Shares - MarketBeat
Zacks Research Brokers Cut Earnings Estimates for Omnicell - MarketBeat
Why Omnicell Inc. stock is favored by pension funds2025 Valuation Update & Entry Point Confirmation Signals - Улправда
Will Omnicell Inc. (OC9) stock remain on Wall Street radarJuly 2025 Gainers & Weekly Consistent Profit Watchlists - Улправда
Will Omnicell Inc. stock benefit from AI adoptionJuly 2025 Spike Watch & Comprehensive Market Scan Insights - Улправда
Is Omnicell Inc. (OC9) stock a top hedge fund pickMarket Activity Recap & Safe Entry Momentum Tips - Улправда
Omnicell (OMCL) Receives Upgrade to Overweight by Keybanc | OMCL Stock News - GuruFocus
Omnicell stock upgraded at KeyBanc (OMCL:NASDAQ) - Seeking Alpha
Omnicell (NASDAQ:OMCL) Shares Gap UpStill a Buy? - MarketBeat
Why Omnicell’s Stock Is Suddenly Surging Higher - TipRanks
This Airbnb Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday - Benzinga
Omnicell (OMCL) Receives Upgrade Amid Promising Growth Potential - GuruFocus
Omnicell stock hits 52-week high at 47.69 USD By Investing.com - Investing.com Nigeria
KeyBanc upgrades Omnicell stock rating to Overweight on potential "super-cycle - Investing.com Canada
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Omnicell (NASDAQ:OMCL) Reaches New 12-Month HighShould You Buy? - MarketBeat
Omnicell stock hits 52-week high at 47.69 USD - Investing.com India
Is Omnicell (OMCL) Fairly Priced After Recent Share Price Recovery? - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 9.74% Potential Upside in Healthcare Tech - DirectorsTalk Interviews
Will Omnicell Inc. stock attract more institutional investors2026 world cup usa national team group stage goalkeepers transition play odds analysis guide - ulpravda.ru
OMCL Analyst Rating Update: Wells Fargo Raises Price Target | OM - GuruFocus
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs - Yahoo Finance
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs - The Motley Fool
Voya Investment Management LLC Cuts Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell shares climb 4% after strong Q3 beat and raised 2025 outlook - MSN
Implied volatility surging for Omnicell stock options - MSN
Implied Volatility Surging for Omnicell Stock Options - sharewise.com
There's No Escaping Omnicell, Inc.'s (NASDAQ:OMCL) Muted Revenues Despite A 27% Share Price Rise - 富途牛牛
Omnicell (NASDAQ:OMCL) Has Some Difficulty Using Its Capital Effectively - Yahoo Finance
Omnicell, Inc. $OMCL Shares Sold by Squarepoint Ops LLC - MarketBeat
Omnicell, Inc. $OMCL Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
How Omnicell Inc. stock benefits from strong dollar2025 Momentum Check & Community Trade Idea Sharing Platform - Улправда
Omnicell (OMCL) Gets a Buy from Piper Sandler - The Globe and Mail
Bank Watch: Why Omnicell Inc. stock is considered a top pickCEO Change & Smart Investment Allocation Insights - Улправда
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):